The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature

Cardiovascular Research

Volumn 73, Issue 3, 2007, Pages 587-596

  Favaloro, Joanne L ^a   Kemp Harper, Barbara K ^a  

^a Department of Physiology School of Biomedical Sciences   (Australia)

Author keywords

Coronary circulation; Nitric oxide; Nitroxyl anion; Redox signaling; Vasoactive agents

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); CALCITONIN GENE RELATED PEPTIDE; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; HYDROXOCOBALAMIN; ISOPRENALINE; NITRIC OXIDE; NITROXYL ANION; PHENYLEPHRINE; POTASSIUM CHANNEL; SCAVENGER; THROMBOXANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART BLOOD VESSEL; HEART CONTRACTION; ISOLATED HEART; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULARIZATION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ANIONS; ANTIOXIDANTS; CALCITONIN GENE-RELATED PEPTIDE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; HEART RATE; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; NIFEDIPINE; NITRITES; NITROGEN OXIDES; OXADIAZOLES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PERFUSION; POTASSIUM; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM NITRITE; VASODILATION;

EID: 33846056511     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.11.018     Document Type: Article

References (37)

1. Bartberger M., Fukuto J., and Houk K. On the acidity and reactivity of HNO in aqueous solution and biological systems. Proc Natl Acad Sci U S A 98 (2001) 2194-2198
2. Hobbs A.J., Fukuto J.M., and Ignarro L.J. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A 91 (1994) 10992-10996
3. {radical dot} from NO synthase. Proc Natl Acad Sci U S A 93 (1996) 14492-14497
4. Adak S., Wang Q., and Stuehr D. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. J Biol Chem 275 (2000) 33554-33561
5. Pufahl R.A., Wishnok J.S., and Marletta M.A. Hydrogen peroxide-supported oxidation of NG-hydroxy-l-arginine by nitric oxide synthase. Biochem 34 (1995) 1930-1941
6. Sharpe M., and Cooper C. Reactions of nitric oxide with mitocondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. Biochem J 332 (1998) 9-19
7. - donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318 (1995) 279-285
8. Ellis A., Li G.G., and Rand M.J. Differential actions of l-cysteine on response to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Brit J Pharmacol 129 (2000) 315-322
9. V channels to vasodilate resistance arteries. Hypertension 41 (2003) 1301-1307
10. Wanstall J., Jeffery T., Gambino A., Lovren F., and Triggle C. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol 134 (2001) 463-472
11. De Witt B., Marrone J., Kaye A., Keefer L., and Kadowitz P. Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur J Pharmacol 430 (2001) 311-315
12. Ma X., Gao F., Liu G., Lopez B., Christopher T., Fukuto J., et al. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci 96 (1999) 14617-14622
13. Fukuto J., Hobbs A., and Ignarro L. Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to biological activity of HNO. Biochem Biophys Res Commun 196 (1993) 707-713
14. Wink D., Miranda K., Katori T., Mancardi D., Thomas D., Ridnour L., et al. Vascular signalling by free radicals. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. Am J Physiol 285 (2003) H22264-H22276
15. Miranda K.M., Paolocci N., Katori T., Thomas D., Ford E., Bartberger M., et al. A biochemical rationale for the discrete behaviour of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci 100 (2003) 9196-9201
16. -) using l-cysteine. Biochem Biophys Res Commun 201 (1994) 54-62
17. Miranda K., Nims R., Thomas D., Espey M., Citrin D., Bartberger M., et al. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. J Inorg Biochem 93 (2003) 52-60
18. Paolocci N., Kartori T., Champion H., St. John M., Miranda K., Fukuto J., et al. Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from b-adrenergic signaling. Proc Natl Acad Sci U S A 100 (2003) 5537-5542
19. Feelisch M. Nitroxyl gets to the heart of the matter. Proc Natl Acad Sci U S A 100 (2003) 4978-4980
20. Langendorff O. Untersuchargen am iiberlebender Saugethierherzer. Pflugers Arch 61 (1895) 295-303
21. Broadley K. The Langendorff heart preparation - reappraisal of it's role as a research and teaching model for coronary vasoactive drugs. J Pharmacol Methods 2 (1979) 143-156
22. Nelli S., Hillen M., Buyukafsar K., and Martin W. Oxidation of nitroxyl anion to nitric oxide by copper ions. Br J Pharmacol 131 (2000) 356-362
23. Nelli S., McIntosh L., and Martin W. Role of copper ions and cytochrome P450 in the vasodilator actions of the nitroxyl anion generator, Angeli's salt, on rat aorta. Eur J Pharmacol 412 (2001) 281-289
24. Li C.G., Karagiannis J., and Rand M.J. Comparison of the redox forms of nitrogen monoxide with the nitregic transmitter in the rat anococcygeus muscle. Br J Pharmacol 127 (1999) 826-834
25. Costa G., Labadia A., Triguero D., Jimenez A., and Garcia-Pascual A. Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative forms of NO. N-S Arch Pharmacol 364 (2001) 516-523
26. {radical dot}) the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem Pharmacol 51 (1996) 1593-1600
27. +-ATPase. Am J Physiol 290 (2006) H1617-H1623
28. Li P., Zou A., and Campbell W. Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators. Hypertension 29 (1997) 262-267
29. Dellsperger K.C. Potassium channels in the coronary circulation. Clin Exp Pharmacol Physiol 23 (1996) 1096-1101
30. Bell D., and McDermott B. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 48 (1996) 253-288
31. Chang Y., Stover S., and Hoover D. Regional localization and abundance of calcitonin gene-related peptide receptors in guinea pig heart. J Mol Cell Cardiol 33 (2001) 745-754
32. Brain S., and Grant A. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84 (2004) 903-934
33. + channels. Nature 344 (1990) 770-773
34. Hu C., Li Y., and Deng H. The cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide. Eur J Pharmacol 369 (1999) 189-194
35. Booth B., Tabrizi-Fard M., and Fung H. Calcitonin gene-related peptide-dependent vascular relaxation of rat aorta. Biochem Pharmacol 59 (2000) 1603-1609
36. + Channel blockade. Life Sci 71 (2002) 2299-2309
37. Paolocci N., Saavedra W., Miranda K., Martignani C., Isoda T., Hare J., et al. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A 98 (2001) 10463-10468